Literature DB >> 14708689

Adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B: a review of the major clinical studies.

Geoffrey Dusheiko1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708689     DOI: 10.1016/s0168-8278(03)00314-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

Review 1.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

2.  Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects.

Authors:  De-Qing Sun; Hai-Sheng Wang; Mei-Yuan Ni; Ben-Jie Wang; Rui-Chen Guo
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.